Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
AIDS and Behavior
Published in: AIDS and Behavior 3/2015

01-03-2015 | Original Paper

Differential Risk Factors for HIV Drug and Sex Risk-Taking Among Non-treatment-seeking Hospitalized Injection Drug Users

Authors: Denise Crooks, Judith Tsui, Bradley Anderson, Shernaz Dossabhoy, Debra Herman, Jane M. Liebschutz, Michael D. Stein

Published in: AIDS and Behavior | Issue 3/2015

Login to get access

Abstract

Injection drug users (IDUs) are at increased risk of contracting HIV. From a clinical trial assessing an intervention to enhance the linkage of hospitalized patients to opioid treatment after discharge, we conducted multivariate analysis of baseline data from hospitalized IDUs with a history of opioid dependence (n = 104) to identify differences in factors predicting HIV drug and sex risk behaviors. Factors significantly associated with HIV drug risk were being non-Hispanic Caucasian and recent cocaine use. Being female, binge drinking, and poorer mental health were significantly associated with higher sex risk. Because factors predicting HIV sex risk behaviors differ from those predicting HIV drug risk, interventions aimed at specific HIV risks should have different behavioral and substance use targets.
Literature
1.
Prejean J, Song R, Hernandez A, Ziebell R, Green T, Walker F, et al. Estimated HIV incidence in the United States, 2006–2009. PLoS One. 2011;6(8):e17502.CrossRefPubMedCentralPubMed
2.
Santibanez SS, Garfein RS, Swartzendruber A, Purcell DW, Paxton LA, Greenberg AE. Update and overview of practical epidemiologic aspects of HIV/AIDS among injection drug users in the United States. J Urban Health. 2006;83(1):86–100.CrossRefPubMedCentralPubMed
3.
Rondinelli AJ, Ouellet LJ, Strathdee SA, Latka MH, Hudson SM, Hagan H, et al. Young adult injection drug users in the United States continue to practice HIV risk behaviors. Drug Alcohol Depend. 2009;104(1–2):167–74.CrossRefPubMed
4.
Brooks A, Meade CS, Potter JS, Lokhnygina Y, Calsyn DA, Greenfield SF. Gender differences in the rates and correlates of HIV risk behaviors among drug abusers. Subst Use Misuse. 2010;45(14):2444–69.CrossRefPubMedCentralPubMed
5.
Magnus M, Kuo I, Phillips G 2nd, Rawls A, Peterson J, Montanez L, et al. Differing HIV risks and prevention needs among men and women injection drug users (IDU) in the District of Columbia. J Urban Health. 2013;90(1):157–66.CrossRefPubMedCentralPubMed
6.
Wu LT, Ling W, Burchett B, Blazer DG, Shostak J, Woody GE. Gender and racial/ethnic differences in addiction severity, HIV risk, and quality of life among adults in opioid detoxification: results from the National Drug Abuse Treatment Clinical Trials Network. Subst Abuse Rehabil. 2010;2010(1):13–22.CrossRefPubMed
7.
8.
Howe CJ, Cole SR, Ostrow DG, Mehta SH, Kirk GD. A prospective study of alcohol consumption and HIV acquisition among injection drug users. AIDS. 2011;25(2):221–8.CrossRefPubMedCentralPubMed
9.
Leigh BC, Ames SL, Stacy AW. Alcohol, drugs, and condom use among drug offenders: an event-based analysis. Drug Alcohol Depend. 2008;93(1–2):38–42.CrossRefPubMedCentralPubMed
10.
Rees V, Saitz R, Horton NJ, Samet J. Association of alcohol consumption with HIV sex- and drug-risk behaviors among drug users. J Subst Abuse Treat. 2001;21(3):129–34.CrossRefPubMed
11.
Rees VW, Saitz R, Savetsky J, Samet JH, editors. Influence of alcohol problems on HIV-risk behavior among a cohort of injection drug users. College of Problems on Drug Dependence Annual Meeting; 2000; San Juan, Puerto Rico.
12.
DeBeck K, Kerr T, Li K, Fischer B, Buxton J, Montaner J, et al. Smoking of crack cocaine as a risk factor for HIV infection among people who use injection drugs. CMAJ. 2009;181(9):585–9.CrossRefPubMedCentralPubMed
13.
Raj A, Saitz R, Cheng DM, Winter M, Samet JH. Associations between alcohol, heroin, and cocaine use and high risk sexual behaviors among detoxification patients. Am J Drug Alcohol Abuse. 2007;33(1):169–78.CrossRefPubMed
14.
Chaudhry AA, Botsko M, Weiss L, Egan JE, Mitty J, Estrada B, et al. Participant characteristics and HIV risk behaviors among individuals entering integrated buprenorphine/naloxone and HIV care. J Acquir Immune Defic Syndr. 2011;56(Suppl 1):S14–21.CrossRefPubMed
15.
Perdue T, Hagan H, Thiede H, Valleroy L. Depression and HIV risk behavior among Seattle-area injection drug users and young men who have sex with men. AIDS Educ Prev. 2003;15(1):81–92.CrossRefPubMed
16.
Pilowsky DJ, Wu LT, Burchett B, Blazer DG, Ling W. Depressive symptoms, substance use, and HIV-related high-risk behaviors among opioid-dependent individuals: results from the Clinical Trials Network. Subst Use Misuse. 2011;46(14):1716–25.CrossRefPubMedCentralPubMed
17.
Aidala A, Cross JE, Stall R, Harre D, Sumartojo E. Housing status and HIV risk behaviors: implications for prevention and policy. AIDS Behav. 2005;9(3):251–65.CrossRefPubMed
18.
Towe VL, Sifakis F, Gindi RM, Sherman SG, Flynn C, Hauck H, et al. Prevalence of HIV infection and sexual risk behaviors among individuals having heterosexual sex in low income neighborhoods in Baltimore, MD: the BESURE study. J Acquir Immune Defic Syndr. 2010;53(4):522–8.CrossRefPubMed
19.
Stein MD, Charuvastra A, Anderson B, Sobota M, Friedmanna PD. Alcohol and HIV risk taking among intravenous drug users. Addict Behav. 2002;27(5):727–36.CrossRefPubMed
20.
Ropelewski LR, Mancha BE, Hulbert A, Rudolph AE, Martins SS. Correlates of risky injection practices among past-year injection drug users among the US general population. Drug Alcohol Depend. 2011;116(1–3):64–71.CrossRefPubMedCentralPubMed
21.
22.
Bourgois P, Martinez A, Kral A, Edlin BR, Schonberg J, Ciccarone D. Reinterpreting ethnic patterns among white and African American men who inject heroin: a social science of medicine approach. PLoS Med. 2006;3(10):e452.CrossRefPubMedCentralPubMed
23.
Hayaki J, Anderson B, Stein M. Sexual risk behaviors among substance users: relationship to impulsivity. Psychol Addict Behav. 2006;20(3):328–32.CrossRefPubMed
24.
Stein M, Anderson B, Charuvastra A, Friedmann P. Alcohol use and sexual risk taking among hazardously drinking drug injectors who attend needle exchange. Alcohol Clin Exp Res. 2001;25(10):1487–93.CrossRefPubMed
25.
Meade CS, Graff FS, Griffin ML, Weiss RD. HIV risk behavior among patients with co-occurring bipolar and substance use disorders: associations with mania and drug abuse. Drug Alcohol Depend. 2008;92(1–3):296–300.CrossRefPubMedCentralPubMed
26.
Corneil TA, Kuyper LM, Shoveller J, Hogg RS, Li K, Spittal PM, et al. Unstable housing, associated risk behaviour, and increased risk for HIV infection among injection drug users. Health Place. 2006;12(1):79–85.CrossRefPubMed
27.
Linton SL, Celentano DD, Kirk GD, Mehta SH. The longitudinal association between homelessness, injection drug use, and injection-related risk behavior among persons with a history of injection drug use in Baltimore, MD. Drug Alcohol Depend. 2013;132(3):457–65.CrossRefPubMedCentralPubMed
28.
Gyarmathy VA, Neaigus A. The relationship of sexual dyad and personal network characteristics and individual attributes to unprotected sex among young injecting drug users. AIDS Behav. 2009;13(2):196–206.CrossRefPubMedCentralPubMed
29.
Meade CS, Weiss RD, Fitzmaurice GM, Poole SA, Subramaniam GA, Patkar AA, et al. HIV risk behavior in treatment-seeking opioid-dependent youth: results from a NIDA clinical trials network multisite study. J Acquir Immune Defic Syndr. 2010;55(1):65–72.CrossRefPubMedCentralPubMed
30.
Evans JL, Hahn JA, Page-Shafer K, Lum PJ, Stein ES, Davidson PJ, et al. Gender differences in sexual and injection risk behavior among active young injection drug users in San Francisco (the UFO Study). J Urban Health. 2003;80(1):137–46.CrossRefPubMedCentralPubMed
31.
Golub ET, Strathdee SA, Bailey SL, Hagan H, Latka MH, Hudson SM, et al. Distributive syringe sharing among young adult injection drug users in five US cities. Drug Alcohol Depend. 2007;91(Suppl 1):S30–8.CrossRefPubMed
32.
Thiede H, Hagan H, Campbell JV, Strathdee SA, Bailey SL, Hudson SM, et al. Prevalence and correlates of indirect sharing practices among young adult injection drug users in five US cities. Drug Alcohol Depend. 2007;91(Suppl 1):S39–47.CrossRefPubMed
33.
McLellan AT, Kushner H, Metzger D, Peters R, Smith I, Grissom G, et al. The fifth edition of the Addiction Severity Index. J Subst Abuse Treat. 1992;9(3):199–213.CrossRefPubMed
34.
Ware J Jr, Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34(3):220–33.CrossRefPubMed
35.
Metzger D, Woody G, Navaline H. The risk assessment battery: validity and reliability. Paper presented at the 6th Annual Meeting of the National Cooperative Vaccine Development Groups for AIDS, Alexandria, VA; 1993.
36.
Bollen KA, Stine R. Direct and indirect effects: classical and bootstrap estimates of variability. Sociol Methodol. 1990;20:115–40.CrossRef
37.
Moore D, McCabe G. Introduction to the practice of statistics. 5th ed. New York: W.H. Freeman; 2005.
38.
Strathdee SA, Hallett TB, Bobrova N, Rhodes T, Booth R, Abdool R, et al. HIV and risk environment for injecting drug users: the past, present, and future. Lancet. 2010;376(9737):268–84.CrossRefPubMed
39.
Macarthur GJ, Minozzi S, Martin N, Vickerman P, Deren S, Bruneau J, et al. Opiate substitution treatment and HIV transmission in people who inject drugs: systematic review and meta-analysis. BMJ. 2012;345:e5945.CrossRefPubMedCentralPubMed
40.
Stein M. Medical consequences of substance abuse. Psychiatr Clin North Am. 1999;22(2):351–70.CrossRef
41.
Tyndall MW, Patrick D, Spittal P, Li K, O’Shaughnessy MV, Schechter MT. Risky sexual behaviours among injection drugs users with high HIV prevalence: implications for STD control. Sex Transm Infect. 2002;78(Suppl 1):i170–5.CrossRefPubMedCentralPubMed
42.
Mitchell MM, Latimer WW. Gender differences in high risk sexual behaviors and injection practices associated with perceived HIV risk among injection drug users. AIDS Educ Prev. 2009;21(4):384–94.CrossRefPubMed
43.
Wechsberg WM, Jewkes R, Novak SP, Kline T, Myers B, Browne FA, et al. A brief intervention for drug use, sexual risk behaviours and violence prevention with vulnerable women in South Africa: a randomised trial of the Women’s Health CoOp. BMJ Open. 2013;3(5):e002622.
44.
Bruneau J, Lamothe F, Soto J, Lachance N, Vincelette J, Vassal A, et al. Sex-specific determinants of HIV infection among injection drug users in Montreal. CMAJ. 2001;164(6):767–73.PubMedCentralPubMed
45.
Dick DM, Smith G, Olausson P, Mitchell SH, Leeman RF, O’Malley SS, et al. Understanding the construct of impulsivity and its relationship to alcohol use disorders. Addict Biol. 2010;15(2):217–26.CrossRefPubMedCentralPubMed
46.
Rehm J, Shield KD, Joharchi N, Shuper PA. Alcohol consumption and the intention to engage in unprotected sex: systematic review and meta-analysis of experimental studies. Addiction. 2012;107(1):51–9.CrossRefPubMed
47.
Scott-Sheldon LA, Carey MP, Vanable PA, Senn TE, Coury-Doniger P, Urban MA. Alcohol consumption, drug use, and condom use among STD clinic patients. J Stud Alcohol Drugs. 2009;70(5):762–70.CrossRefPubMedCentralPubMed
48.
Hutton HE, McCaul ME, Santora PB, Erbelding EJ. The relationship between recent alcohol use and sexual behaviors: gender differences among sexually transmitted disease clinic patients. Alcohol Clin Exp Res. 2008;32(11):2008–15.PubMedCentralPubMed
49.
Santelli JS, Brener ND, Lowry R, Bhatt A, Zabin LS. Multiple sexual partners among US adolescents and young adults. Fam Plann Perspect. 1998;30(6):271–5.CrossRefPubMed
50.
Morrill AC, Kasten L, Urato M, Larson MJ. Abuse, addiction, and depression as pathways to sexual risk in women and men with a history of substance abuse. J Subst Abuse. 2001;13(1–2):169–84.CrossRefPubMed
51.
Plotzker RE, Metzger DS, Holmes WC. Childhood sexual and physical abuse histories, PTSD, depression, and HIV risk outcomes in women injection drug users: a potential mediating pathway. Am J Addict. 2007;16(6):431–8.CrossRefPubMed
52.
Verdejo-Garcia A, Lawrence AJ, Clark L. Impulsivity as a vulnerability marker for substance-use disorders: review of findings from high-risk research, problem gamblers and genetic association studies. Neurosci Biobehav Rev. 2008;32(4):777–810.CrossRefPubMed
53.
Kirby KN, Petry NM. Heroin and cocaine abusers have higher discount rates for delayed rewards than alcoholics or non-drug-using controls. Addiction. 2004;99(4):461–71.CrossRefPubMed
54.
Petry NM, Bickel WK, Arnett M. Shortened time horizons and insensitivity to future consequences in heroin addicts. Addiction. 1998;93(5):729–38.CrossRefPubMed
55.
Odum AL, Madden GJ, Badger GJ, Bickel WK. Needle sharing in opioid-dependent outpatients: psychological processes underlying risk. Drug Alcohol Depend. 2000;60(3):259–66.CrossRefPubMed
56.
Tull M, Gratz K. Major depression and risky sexual behavior among substance dependent patients: the moderating roles of distress tolerance and gender. Cogn Ther Res. 2013;37(3):483–97.CrossRef
57.
Calsyn DA, Campbell AN, Tross S, Hatch-Maillette MA. Is monogamy or committed relationship status a marker for low sexual risk among men in substance abuse treatment? Clinical and methodological considerations. Am J Drug Alcohol Abuse. 2011;37(5):294–300.CrossRefPubMedCentralPubMed
58.
Kapadia F, Latka MH, Wu Y, Strathdee SA, Mackesy-Amiti ME, Hudson SM, et al. Longitudinal determinants of consistent condom use by partner type among young injection drug users: the role of personal and partner characteristics. AIDS Behav. 2011;15(7):1309–18.CrossRefPubMedCentralPubMed
59.
Shanahan CW, Beers D, Alford DP, Brigandi E, Samet JH. A transitional opioid program to engage hospitalized drug users. J Gen Intern Med. 2010;25(8):803–8.CrossRefPubMedCentralPubMed
60.
O’Toole TP, Pollini RA, Ford D, Bigelow G. Physical health as a motivator for substance abuse treatment among medically ill adults: is it enough to keep them in treatment? J Subst Abuse Treat. 2006;31(2):143–50.CrossRefPubMed
Metadata
Title
Differential Risk Factors for HIV Drug and Sex Risk-Taking Among Non-treatment-seeking Hospitalized Injection Drug Users
Authors
Denise Crooks
Judith Tsui
Bradley Anderson
Shernaz Dossabhoy
Debra Herman
Jane M. Liebschutz
Michael D. Stein
Publication date
01-03-2015
Publisher
Springer US
Published in
AIDS and Behavior / Issue 3/2015
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-014-0754-7

Other articles of this Issue 3/2015

AIDS and Behavior 3/2015 Go to the issue

Original Paper

Factors Associated with HIV-Testing and Acceptance of an Offer of Home-Based Testing by Men in Rural Zambia

Original Paper

Experiences and Correlates of HIV Self-Testing Among Men Who Have Sex with Men in Jiangsu Province, China

Original Paper

Approval and Potential Use of Over-the-Counter HIV Self-Tests: The Opinion of Participants in a Street Based HIV Rapid Testing Program in Spain

Original Paper

Acceptability and Feasibility of Using Established Geosocial and Sexual Networking Mobile Applications to Promote HIV and STD Testing Among Men Who Have Sex with Men

Original Paper

The Effects of Sexual Sensation Seeking and Alcohol Use on Risky Sexual Behavior Among Men Who Have Sex with Men

Original Paper

HIV Testing Behaviors and Perceptions of Risk of HIV Infection Among MSM with Main Partners
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits